Johnson & Johnson single-shot COVID-19 vaccine appears 66% effective overall in global trial

Virus Outbreak-Johnson Johnson Vaccine

Johnson & Johnson's long-awaited vaccine appears to protect against COVID-19 with just one shot. It's not as strong as some of its two-shot rivals but still potentially helpful for a world in dire need of more doses.



Post a Comment

[facebook][blogger][disqus][spotim]

MKRdezign

Contact Form

Name

Email *

Message *

Powered by Blogger.
Javascript DisablePlease Enable Javascript To See All Widget